Related references
Note: Only part of the references are listed.Assessing tissue damage in multiple sclerosis: a biomarker approach
J. Burman et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Cerebrospinal Fluid Neurofilament Concentration Reflects Disease Severity in Frontotemporal Degeneration
Carole S. Scherling et al.
ANNALS OF NEUROLOGY (2014)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions
Maria C. Sadaba et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Neurofilaments as biomarkers in multiple sclerosis
Charlotte E. Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
Maria Jose Magraner et al.
NEURORADIOLOGY (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
Evidence for a two-stage disability progression in multiple sclerosis
Emmanuelle Leray et al.
BRAIN (2010)
MULTIPLE SCLEROSIS Oligoclonal bands still yield clues about multiple sclerosis
Anne H. Cross et al.
NATURE REVIEWS NEUROLOGY (2010)
Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF
Clas Malmestrom et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis
Bettina Kuenz et al.
PLOS ONE (2008)
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis
Dun Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
Clinically isolated syndromes -: A new oligoclonal band test accurately predicts conversion to MS
J Masjuan et al.
NEUROLOGY (2006)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study
A Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
The pathogenesis of primary progressivie multiple sclerosis: antibody-mediated attack and no repair?
MP Pender
JOURNAL OF CLINICAL NEUROSCIENCE (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability
N De Stefano et al.
ARCHIVES OF NEUROLOGY (2002)
Brain atrophy in clinically early relapsing-remitting multiple sclerosis
DT Chard et al.
BRAIN (2002)
Relapses and progression of disability in multiple sclerosis.
C Confavreux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation
A Bitsch et al.
BRAIN (2000)
Share Paper
